Officials Warn Of Deaths Linked To Bayer Drug

Law360, New York (November 24, 2008, 12:00 AM EST) -- Canadian health officials have issued a warning about Bayer HealthCare's MabCampath after reports of infection-related deaths linked to the immune system-suppressing leukemia medication.

Health Canada said researchers conducting clinical trials of MabCampath in the U.S. reported that six out of 51 patients died after being treated with the drug after a combination therapy of two other anti-leukemia drugs — fludarabine and rituximab.

All six deceased patients died of infections that were either bacterial, fungal or viral in nature, the agency said.

MabCampath, which is jointly marketed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.